Corrigendum to "In vitro permeation of desmopressin across rabbit nasal mucosa from liquid nasal sprays: The enhancing effect of potassium sorbate" [Eur. J. Pharm. Sci. 37 (2009) 36-42] (DOI:10.1016/j.ejps.2008.12.015);In vitro permeation of desmopressin across rabbit nasal mucosa from liquid nasal sprays: The enhancing effect of potassium sorbate

European Journal of Pharmaceutical Sciences

Volumn 37, Issue 1, 2009, Pages 36-42

  Bortolotti, Fabrizio ^a   Balducci, Anna Giulia ^a,b   Sonvico, Fabio ^b   Russo, Paola ^c   Colombo, Gaia ^a  

^a UNIVERSITY OF FERRARA   (Italy)

^b UNIVERSITY OF PARMA   (Italy)

^c UNIVERSITY OF SALERNO   (Italy)

Author keywords

Desmopressin; Nasal spray; Potassium sorbate; Preservative

Indexed keywords

BENZALKONIUM; CHLORBUTOL; DESMOPRESSIN; ION; SORBATE POTASSIUM; SORBIC ACID;

ANIMAL CELL; AQUEOUS SOLUTION; ARTICLE; CONCENTRATION (PARAMETERS); DRUG BIOAVAILABILITY; DRUG PENETRATION; DRUG SAFETY; DRUG TRANSPORT; IN VITRO STUDY; NONHUMAN; NOSE MUCOSA; PRIORITY JOURNAL; RABBIT;

EID: 60749086449     PISSN: 09280987     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejps.2009.10.011     Document Type: Erratum

References (24)

1. Bommer R., Kern J., Hennes K., and Zwisler W. Preservative-free nasal drug-delivery systems. Med. Device Technol. 15 (2004) 14-16, 18
2. Cho J.H., Kwun Y.S., Jang H.S., Kang J.M., Won Y.S., and Yoon H.R. Long-term use of preservatives on rat nasal respiratory mucosa: effects of benzalkonium chloride and potassium sorbate. Laryngoscope 110 (2000) 312-317
3. Colombo P., Cagnani S., Sonvico F., Santi P., Russo P., and Colombo G. Biological in vitro models for absorption by nonoral routes. In: Taylor J.B., and Triggle D.J. (Eds). Comprehensive Medicinal Chemistry II (2007), Elsevier Ltd., Oxford, UK 279-299
4. Cvetkovic R.S., and Plosker G.L. Desmopressin: in adults with nocturia. Drugs 65 (2005) 99-107 (discussion 108-109)
5. Das P., Carcao M., and Hitzler J. DDAVP-induced hyponatremia in young children. J. Pediatr. Hematol. Oncol. 27 (2005) 330-332
6. Dehoorne J.L., Raes A.M., van Laecke E., Hoebeke P., and Vande Walle J.G. Desmopressin toxicity due to prolonged half-life in 18 patients with nocturnal enuresis. J. Urol. 176 (2006) 754-757 (discussion 757-758)
7. Graf P. Benzalkonium chloride as a preservative in nasal solutions: re-examining the data. Respir. Med. 95 (2001) 728-733
8. Higashiyama M., Inada K., Ohtori A., and Kakehi K. NMR analysis of ion pair formation between timolol and sorbic acid in ophthalmic preparations. J. Pharm. Biomed. Anal. 43 (2007) 1335-1342
9. Higashiyama M., Inada K., Ohtori A., and Tojo K. Improvement of the ocular bioavailability of timolol by sorbic acid. Int. J. Pharm. 272 (2004) 91-98
10. Ho C.Y., Wu M.C., Lan M.Y., Tan C.T., and Yang A.H. In vitro effects of preservatives in nasal sprays on human nasal epithelial cells. Am. J. Rhinol. 22 (2008) 125-129
11. Jonsson K., Alfredsson K., Soderberg-Ahlm C., Critchley H., Broeders A., and Ohlin M. Evaluation of the degradation of desaminol,d-arginine8-vasopressin by nasal mucosa. Acta Endocrinol. (Copenh.) 127 (1992) 27-32
12. Joukhadar C., Schenk B., Kaehler S.T., Kollenz C.J., Bauer P., Muller M., and Eichler H.G. A replicate study design for testing bioequivalence: a case study on two desmopressin nasal spray preparations. Eur. J. Clin. Pharmacol. 59 (2003) 631-636
13. Law S.L., Huang K.J., and Chou H.Y. Preparation of desmopressin-containing liposomes for intranasal delivery. J. Control. Release 70 (2001) 375-382
14. Law S.L., Huang K.J., and Chou V.H. Stability of desmopressin loaded in liposomes. J. Liposome Res. 13 (2003) 269-277
15. Lebe E., Baka M., Yavasoglu A., Aktug H., Ates U., and Uyanikgil Y. Effects of preservatives in nasal formulations on the mucosal integrity: an electron microscopic study. Pharmacology 72 (2004) 113-120
16. Merkus F.W., Verhoef J.C., Schipper N.G., and Marttin E. Nasal mucociliary clearance as a factor in nasal drug delivery. Adv. Drug Deliv. Rev. 29 (1998) 13-38
17. Merkus P., Romeijn S.G., Verhoef J.C., Merkus F.W., and Schouwenburg P.F. Classification of cilio-inhibiting effects of nasal drugs. Laryngoscope 111 (2001) 595-602
18. Odeh M., and Oliven A. Coma and seizures due to severe hyponatremia and water intoxication in an adult with intranasal desmopressin therapy for nocturnal enuresis. J. Clin. Pharmacol. 41 (2001) 582-584
19. Robson W.L., Leung A.K., and Norgaard J.P. The comparative safety of oral versus intranasal desmopressin for the treatment of children with nocturnal enuresis. J. Urol. 178 (2007) 24-30
20. Russo P., Sacchetti C., Pasquali I., Bettini R., Massimo G., Colombo P., and Rossi A. Primary microparticles and agglomerates of morphine for nasal insufflation. J. Pharm. Sci. 95 (2006) 2553-2561
21. Sacchetti C., Artusi M., Santi P., and Colombo P. Caffeine microparticles for nasal administration obtained by spray drying. Int. J. Pharm. 242 (2002) 335-339
22. van de Donk H.J., van den Heuvel A.G., Zuidema J., and Merkus F.W. The effects of nasal drops and their additives on human nasal mucociliary clearance. Rhinology 20 (1982) 127-137
23. Verse T., Sikora C., Rudolph P., and Klocker N. The tolerability of nasal drugs with special regard to preservatives and physico-chemical parameters. Laryngorhinootologie 82 (2003) 782-789
24. Xiang J., Fang X., and Li X. Transbuccal delivery of 2′,3′-dideoxycytidine: in vitro permeation study and histological investigation. Int. J. Pharm. 231 (2002) 57-66